Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|June 1, 1989
[Systematic study of various tumoral markers in prevalent bone metastasis]L Euller-Ziegler, D Pons-Anicet, B P Krebs, et al.
Presse Medicale (Paris, France : 1983)|July 22, 1992
[Prevention of pathological aging. The arterial hypertension example]F Forette, P Bert, V Breuil
Annals of the Rheumatic Diseases|May 14, 2004
Management of osteoarthritis (OA) with an unsupervised home based exercise programme and/or patient administered assessment tools. A cluster randomised controlled trial with a 2x2 factorial designP Ravaud, B Giraudeau, I Logeart, et al.
Presse Medicale (Paris, France : 1983)|December 28, 1985
[Treatment of systemic scleroderma with factor XIII in 86 patients, with long-term follow-up]L Guillevin, L Euller-Ziegler, B Chouvet, et al.
European Journal of Haematology|January 1, 1996
Osteocalcin is not a marker of progress in multiple myeloma. Le Groupe d'Etude et de Recherche sur le Myélome (GERM)O Mejjad, X Le Loët, J P Basuyau, et al.
The European Journal of Medicine|October 1, 1993
Treatment of multiple myeloma with etidronate: results of a multicentre double-blind study. Groupe d'Etudes et de Recherches sur le Myélome (GERM)A Daragon, C Humez, C Michot, et al.
American Journal of Hematology|February 1, 1995
Prognostic factors in low tumour mass asymptomatic multiple myeloma: a report on 91 patients. The Groupe d'Etudes et de Recherche sur le Myélome (GERM)T Facon, J F Menard, J L Michaux, et al.
La Revue De Medecine Interne|January 1, 1993
[Correlation between the serum level of soluble CD16 and the staging of myeloma: study of 214 serums]C Mathiot, B Grosbois, J L Teillaud, et al.
Journal of Clinical Immunology|January 1, 1993
Correlation between soluble serum CD16 (sCD16) levels and disease stage in patients with multiple myelomaC Mathiot, J L Teillaud, M Elmalek, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 29, 2013
Impact of systemic treatment of psoriasis on inflammatory parameters and markers of comorbidities and cardiovascular risk: results of a prospective longitudinal observational studyH Montaudié, C Albert-Sabonnadière, E Acquacalda, et al.
Pageof 5